Covid-19 patients who are 80 or older are hundreds of times more likely to die than those under 40.
That’s partly because they are more likely to have underlying conditions — like diabetes and lung disease — that seem to make the body more vulnerable to Covid-19.
But some scientists suggest another likely, if underappreciated, driver of this increased risk: the aging immune system.
The changes that ripple through our network of immune cells as the decades pass are complex, resulting in an overreaction here, a delayed response there and over all, a strangely altered landscape of immunity.
Scientists who study the aging immune system say that understanding it may lead not only to a clearer sense of how age is connected to disease vulnerability, but to better strategies for vaccines and treatments for Covid-19.
